Comparative analysis among therapeutic modalities in ruptured hepatocellular carcinoma and identification of imaging predictors for survival.

Autor: Nimitrungtawee, Natthaphong¹ (AUTHOR), Phinyo, Phichayut^2,3,4 (AUTHOR), Chalidapong, Piemkamol¹ (AUTHOR), Inmutto, Nakarin¹ (AUTHOR) Nakarin.i@cmu.ac.th

Publikováno v: BMC Cancer. 8/29/2024, Vol. 24 Issue 1, p1-12. 12p.

Extracellular vesicles as a new hope for diagnosis and therapeutic intervention for hepatocellular carcinoma.

Autor: Nimitrungtawee, Natthaphong¹ (AUTHOR), Inmutto, Nakarin¹ (AUTHOR), Chattipakorn, Siriporn C.^2,3,4 (AUTHOR), Chattipakorn, Nipon^2,3,4 (AUTHOR) nchattip@gmail.com

Publikováno v: Cancer Medicine. Dec2021, Vol. 10 Issue 23, p8253-8271. 19p.

Investigating Up-to-Seven Criteria and APRI (AST Platelet Ratio) as Prognostic Factors in Intermediate-Stage Hepatocellular Carcinoma Patients Who Received Transarterial Chemoembolization.

Autor: Inmutto N; Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Nimitrungtawee N; Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Srisuwan T; Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Kattipathanapong T; Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Jantarangkoon A; Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Puttisri O; Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Publikováno v: Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2022 Nov 01; Vol. 23 (11), pp. 3939-3946. Date of Electronic Publication: 2022 Nov 01.